Clinical Trials List
2025-06-01 - 2029-06-30
Phase III
Recruiting7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 郭家佑 無
- Chih-Jen Yang 無
- Inn-Wen Chong 無
- 李玫萱 無
- Ying-Ming Tsai Tsai 無
- 莊政皓 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯皓文 無
- 枋岳甫 無
- Chih-Hung Chen 無
- Chien-Ying Liu 無
- 黃世緯 無
- 林定佑 無
- Chih-Hsi Kuo 無
- Ping-Chih Hsu 無
- 吳浩銘 無
- Ching-His Siao 無
- 邱立忠 無
- Shih-Hong Li 無
- 陳宏吉 無
- Chih-Liang Wang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 趙恒勝 無
- 許志堅 無
- Hsu-ching Huang 無
- Chi-Lu Chiang 無
- Yung-Hung Luo 無
- YEN-HAN TSENG 無
- 廖映庭 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
400 participants
